NovoCure Ltd — Director's Dealing 2016

Dec 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-12-05

Reporting Person: Kirson Eilon D. (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-05	Ordinary Shares	M	156073	$0.17	Acquired	334083	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-05	Options to buy Ordinary Shares	$0.17	M	156073	Disposed	2016-12-12	Ordinary Shares (156073)	Direct

Footnotes

F1: Fully vested and currently exercisable as of the date hereof.